Benzyl (2,6-dioxopiperidin-3-yl)carbamate is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting proteasome inhibition. This chemical is often employed in the development of anticancer agents, as proteasome inhibitors play a critical role in regulating cell cycle progression and apoptosis in cancer cells. Additionally, it is used in the preparation of peptide-based drugs and other therapeutic molecules, contributing to advancements in treatments for diseases such as multiple myeloma and other malignancies. Its structural features make it a valuable building block for designing novel drug candidates with enhanced efficacy and specificity.